GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » 3-Year EPS without NRI Growth Rate

Guangdong Hybribio Biotech Co (SZSE:300639) 3-Year EPS without NRI Growth Rate : -29.70% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co 3-Year EPS without NRI Growth Rate?

Guangdong Hybribio Biotech Co's EPS without NRI for the three months ended in Mar. 2024 was ¥-0.03.

During the past 12 months, Guangdong Hybribio Biotech Co's average EPS without NRI Growth Rate was -96.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -29.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 30.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of Guangdong Hybribio Biotech Co was 126.40% per year. The lowest was -29.70% per year. And the median was 30.50% per year.


Competitive Comparison of Guangdong Hybribio Biotech Co's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Guangdong Hybribio Biotech Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Hybribio Biotech Co's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangdong Hybribio Biotech Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Guangdong Hybribio Biotech Co's 3-Year EPS without NRI Growth Rate falls into.



Guangdong Hybribio Biotech Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Guangdong Hybribio Biotech Co  (SZSE:300639) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Guangdong Hybribio Biotech Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Hybribio Biotech Co (SZSE:300639) Business Description

Traded in Other Exchanges
N/A
Address
D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.

Guangdong Hybribio Biotech Co (SZSE:300639) Headlines

No Headlines